drugset / Trial / NCT06403852

Investigating Near-Threshold Perception During Anesthetic Sedation

NCT06403852

NaSingle-groupOpen-labelBasic science

Summary

The researchers expect to gain a deeper understanding of mental function during different levels of anesthesia, and to evaluate if the use of ultrasonic brain stimulation accelerates return to consciousness. Propofol is FDA approved for use in patients undergoing an anesthetic for medical treatment but is not approved for use in healthy volunteers.

Timeline

Start
2024-05-10
Primary completion
2025-10-03
Completion
2025-10-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 1 ug/ml Intravenous

Indications

No indication recorded.